Proinnovera GmbH   Report issue

For profit Phase 1 Phase 2 Phase 4
Founded: Munster Germany (1997)

Organization Overview

First Clinical Trial
2008
NCT00721331
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Proinnovera GmbH

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acne Vulgaris (Phase 4)

Angioedema (Phase 2)

Dermatitis (Phase 1)

Dermatitis, Atopic (Phase 1)

Eczema (Phase 1)

Lichen Planus (Phase 2)

Lichen Planus, Oral (Phase 2)

Urticaria (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 5
  • # of Trial APIs: 11